Studies on mouse and human hepatoma cells also revealed that VDR activation blocked farnesoid X receptor expression, thereby suppressing cholesterol 7α-hydroxylase expression and decreasing cholesterol levels (29, 30). Here, NR1H4 is linked to hepatocellular carcinoma.